Poland· PL-100246459
Aspar Espefa Premium
A other mineral products product containing magnesii hydrogenoaspartas + kalii hydrogenoaspartas, registered in Poland by Chemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Magnesii hydrogenoaspartas + kalii hydrogenoaspartas is registered in 4 of 19 countries.
Countries holding a registration under ATC A12CX (other mineral products), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Magnesii hydrogenoaspartas + kalii hydrogenoaspartas · ATC A12CX
4 / 19 countries
- Canada
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Magnesii hydrogenoaspartas + Kalii hydrogenoaspartas
- Manufacturer
- Chemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA
- Country
- Poland (PL)
- ATC code
- A12CX
- ATC class
- Other mineral products
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990128914
- gtin05909990128921
- gtin05909990128938
- gtin05909990128945
- gtin05909991456863
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A12CX
Other mineral products, as other registers publish it.
- PolandAsparaginian lekPrzedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
- PolandAsparginFarmaceutyczna Spółdzielnia Pracy FILOFARM
- SwitzerlandFlügge Kieselerde, PulverSchellenberg, Reformprodukte
- SwitzerlandFlügge Kieselerde, PulverSchellenberg, Reformprodukte
- SwitzerlandFlügge Kieselerde, PulverSchellenberg, Reformprodukte
- SwitzerlandFlügge Kieselerde, TablettenSchellenberg, Reformprodukte
- SwitzerlandFlügge Kieselerde, TablettenSchellenberg, Reformprodukte
- NorwayFosfat SASykehusapotekene HF
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccc60698-749b-4ff3-96ab-8ed32d49b05c GET /v1/drugs/ccc60698-749b-4ff3-96ab-8ed32d49b05c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "250 mg + 250 mg",
"packaging": "05909990128914 ¦ OTC ¦ Skasowane ¦ 1542\n25 tabl.\n05909990128921 ¦ OTC ¦ 1543\n50 tabl.\n05909990128938 ¦ OTC ¦ Skasowane ¦ 1544\n50 tabl. w fiolce\n05909990128945 ¦ OTC ¦ 13155\n75 tabl.\n05909991456863 ¦ OTC ¦ 140721\n150 tabl.",
"substance": "Magnesii hydrogenoaspartas 250 mg + Kalii hydrogenoaspartas 250 mg",
"common_name": "Magnesii hydrogenoaspartas + Kalii hydrogenoaspartas",
"pl_product_id": "100246459",
"pozwolenie_nr": "01289",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about magnesii hydrogenoaspartas + kalii hydrogenoaspartas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.